LIVZON PHARMA (01513) spent 31.6851 million yuan to repurchase 848,000 A shares on November 15th.

15/11/2024

GMT Eight

LIVZON PHARMA (01513) announced that on November 15, 2024, the company spent 31.6851 million yuan to repurchase 848,000 A-shares at a repurchase price of 37.11-37,60 yuan per share.

WuXi AppTec(02359): WuXi Fund I intends to subscribe for a 10 million euro investment fund stake from Sofinnova Capital XI SCSp SICAV-RAIF.

The holding subsidiary of China National Nuclear Power (601985.SH), Zhongke Huineng, plans to receive a total of 7.896 billion yuan in additional capital.

Contact: contact@gmteight.com

LIVZON PHARMA (01513) spent 31.6851 million yuan to repurchase 848,000 A shares on November 15th.

RECOMMEND

CH BIOTECH SER(08037): The investment agreement has expired.

OCUMENSION-B (01477) spent 754,500 Hong Kong dollars to repurchase 148,500 shares on November 15.

Bright performance did not boost the stock price, what is the true value of INNOCARE (09969) core product?